Symbol: |
SPG21
|
Description: |
spastic paraplegia 21 (autosomal recessive, Mast syndrome) [Source:HGNC Symbol;Acc:20373]
|
Location: |
Chr15:65255362-65282648[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:191
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPG21 |
Curromycin A.B mixture |
0.012 |
Down |
SPG21 |
NSC 611229 |
0.029 |
Down |
SPG21 |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.02 |
Up |
SPG21 |
NSC 62349 |
0.026 |
Up |
SPG21 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.031 |
Up |
SPG21 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.031 |
Down |
SPG21 |
NSC 633912 |
0.048 |
Down |
SPG21 |
Tellurium, trichloro[1,2-hexanedioato(2-)-O,O']-, ammonium |
0.024 |
Up |
SPG21 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.001 |
Down |
SPG21 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.034 |
Up |
SPG21 |
NSC 650821 |
0.032 |
Up |
SPG21 |
NSC 651668 |
0.026 |
Up |
SPG21 |
1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene |
0.047 |
Up |
SPG21 |
NSC 658874 |
0.006 |
Down |
SPG21 |
Fluorene, 9-bromo-2,4,7-trichloro- |
0.008 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:63
Total:5 Current:1
[First] [Prev]  Next Last 
|